Socio-economic factors affecting delay in
Mycobacterium Tuberculosis (MTB) diagnosis in Central Lancashire
CLAHRC NWC Intern - Linda JohnsonSupervisors: Prof Mark Gabbay and Dr Philippa Olive - Liverpool University, UCLAN and LTHTR
Background
Methods
Tuberculosis (TB) worldwide and within the UK continues
to be a serious public health problem. 6,520 cases of TB
were reported in England in 2014. 646 of these cases were
in the North West.
Highest TB rates are often associated with people living in
socio-economically deprived communities.
(PHE, 2016, MacPherson. P et al, 2016)
Effective diagnosis and treatment is crucial
for improving patient outcomes by
reducing the severity of the disease and
to reduce public health risks of onward
transmission. (Alavi. S et al, 2014)
The study aims to identify factors involved with delays in
MTB diagnosis and treatment for patients at Lancashire
Teaching Hospitals (LTHTR) during 2014 and 2015.
The primary objective is to identify if delays are apparent
and classify them by number of days.
Once identified, are the delays attributable to
patient care-seeking behaviour,
or an National Health Service (NHS)
systems delay.
Also recognition of links associated with
socio–economic deprivation and TB risk
factors such as, alcoholism, imprisonment,
drug use, homelessness and migration.
(MacPherson. P et al, 2016)
ReferencesAlavi SM, Bakhtiyariniya P, Albagi A. Factors Associated With Delay in Diagnosis and Treatment of Pulmonary Tuberculosis. Jundishapur J Microbiol. 2015 Mar; 8(3): e19238. Published online 2015 Mar 21.
MacPherson P, Squires SB, Cleary P, Davies S, Wake C, Dee K, Walker J, Farrow S, McMaster P, Woodhead M, Sloan DJ. Equitable tuberculosis care in the North West of England: analysis of tuberculosis cohort review data. Int J Tuberc Lung Dis. 2016
Jun;20(6):778-85
Public Health England. (November 2015) Tuberculosis in North West England: Annual review (2014 data), 2015. Public Health England: North West. https://www.gov.uk/government/publications/tuberculosis-tb-regional-reports.
World Health Organization 2006. Diagnostic and treatment delay in tuberculosis. WHO-EM/TDR/009/E http://apps.who.int/iris/bitstream/10665/116501/1/dsa710.pdf
A retrospective data analysis is planned, looking at MTB cases (both Pulmonary and Non-pulmonary) treated at LTHTR and
entered into the Enhanced Tuberculosis Surveillance system (ETS) from 1st Jan 2014 – 31st Dec 2015.
In this study ‘Delay’ is defined as the period between two events - The patient delay is the time interval between symptom
onset to first presentation to a health professional. Treatment delay is the period (in days) between symptom onset and the
start of drug treatment. Diagnostic delay interval between symptom onset and diagnosis. Total delay measured from
symptom onset to start of drug treatment.
Aims and Objectives
Results and Discussion
Diagnostic delay Treatment delay
Patient delay Health Service delay
Onset of
symptoms
1st health
seeking
behaviourDate of
diagnosis
Date of
treatment
Total delay
This is a summary of independent research funded by the National Institute for Health Research (NIHR)’s CLAHRC NWC Programme. The views expressed are
those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health
Different delay durations - (WHO, 2006)
This project is still in progress therefore results are not available at present.
The data collection will include:
• Dates of symptom onset, first seen by health professional, diagnosis and treatment commencement.
• Smoking history, age, gender, ethnicity and country of birth.
• History of ability to administer treatment due to: Alcohol misuse, homelessness, imprisonment.
The results will provide information on where targeted education or improved service provision may be needed to reduce TB
burden within Central Lancashire.